Showing results (21-30 of 189) with videos related to
Sort By:
Pageof 19
Expert Review of Clinical Immunology|November 15, 2016
Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritisPedro Mota, Venkat Reddy, David IsenbergExpert Opinion on Pharmacotherapy|April 20, 2025
Challenges of anticoagulation in patients with systemic lupus erythematosusLuigi Zolio, Hannah Cohen, David IsenbergLancet (London, England)|August 27, 2013
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatmentGrainne Murphy, Larissa Lisnevskaia, David IsenbergLancet (London, England)|June 3, 2014
Systemic lupus erythematosusLarissa Lisnevskaia, Grainne Murphy, David IsenbergBritish Journal of Hospital Medicine (London, England : 2005)|October 8, 2014
Abnormal antibodies: what do you do?Maria Mouyis, Maria LeandroBritish Journal of Haematology|May 27, 2009
Rituximab in non-haematological disorders of adults and its mode of actionVickie McDonald, Maria LeandroRheumatology (Oxford, England)|October 25, 2014
Biologic treatment in Sjögren's syndromePablo Ruiz Sada, David Isenberg, Coziana CiurtinClinical and Experimental Rheumatology|June 26, 2010
Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literatureAna Filipa Mourão, Malcolm Rustin, David IsenbergLupus Science & Medicine|March 1, 2017
The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectivenessBorja Gracia-Tello, Amara Ezeonyeji, David IsenbergExpert Opinion on Drug Safety|May 10, 2016
The safety of pharmacological treatment options for lupus nephritisAlba Velo-García, Eleana Ntatsaki, David IsenbergPageof 19